Skip to main content
logo
Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
15.76
+0.26 (1.68%)
At close: Jul 3, 2025, 1:00 PM
15.93
+0.17 (1.08%)
After-hours: Jul 3, 2025, 2:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2018 FY 2017 2017 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '18 Dec '17 2017 - 2018
Biopharmaceutical Products
886.00K
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Products Growth
-61.96%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2018 FY 2017 2017 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '18 Dec '17 2017 - 2018
United States
886.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-61.96%
Log In
Log In
Log In
Log In
Upgrade